Table 1.
Analyte concentrations in DL fluid of pre- and postmenopausal women not taking tamoxifen
| Analyte | Premenopausal | Postmenopausal | p value | ||||
|---|---|---|---|---|---|---|---|
| N | Mean loge (SD) | Geometric mean | N | Mean loge (SD) | Geometric mean | ||
| min,max | min,max | ||||||
| Estradiol pg/mg | 22 | 2.20 (1.65) | 9.03 | 10 | 1.96 (2.12) | 7.10 | 0.91 |
| 1.20,5.37 | 1.27,4.45 | ||||||
| Estrone sulfate ng/mg | 25 | 2.96 (1.40) | 19.3 | 12 | 2.24 (1.95) | 9.39 | 0.27 |
| −1.04,5.34 | −1.90,5.13 | ||||||
| Progesterone ng/mg | 21 | −1.10 (1.84) | 0.33 | 11 | −1.69 (1.76) | 0.18 | 0.38 |
| −4.34,2.25 | −4.42,1.37 | ||||||
| Androstenedione, ng/mg | 23 | −2.54 (1.44) | 0.079 | 12 | −2.84 (1.37) | 0.058 | 0.55 |
| −5.81,−0.34 | −5.12,−0.71 | ||||||
| DHEA ng/mg | 21 | −0.60 (1.47) | 0.55 | 14 | −1.95 (1.67) | 0.142 | 0.02 |
| −3.02,2.21 | −5.52,−0.04 | ||||||
| DHEA sulfate μg/mg | 22 | 1.15 (1.46) | 3.16 | 14 | 0.97 (1.71) | 2.64 | 0.75 |
| −2.36,3.81 | −3.61,3.18 | ||||||
| Cathepsin D ng/mg | 17 | 2.28 (2.37) | 9.78 | 7 | 3.53 (1.22) | 34.1 | 0.10 |
| −3.51,4.94 | 1.86,5.03 | ||||||
| EGF ng/mg | 27 | 1.30 (1.13) | 3.67 | 16 | 1.25 (2.04) | 3.49 | 0.93 |
| −1.94,2.86 | −5.81,3.24 | ||||||
p values are from two-sample t tests